Trial Feasibility of Home Delivery of Colon Capsule Endoscopy Service With the Help of 5 G Technology

Launched by NATIONAL HEALTH SERVICE, UNITED KINGDOM · Jun 13, 2023

Keywords

ClinConnect Summary

The 5G SUCCEEDS study is exploring a new way to deliver a test called Colon Capsule Endoscopy (CCE) directly to patients' homes using advanced 5G technology. This test is important for finding out if someone has bowel issues, like colorectal cancer, but traditionally, patients have to go to a hospital for it. The COVID-19 pandemic has made it harder for people to get colonoscopies due to safety concerns, so this study aims to see if providing CCE at home can help reduce waiting times and make the process easier and more comfortable for patients.

To be eligible for this study, participants should be between the ages of 18 and 55 and have been recommended for a Colon Capsule Endoscopy by their doctor. They should be able to give their consent to join the study and not be pregnant or meet other specific exclusion criteria. If you join the study, you'll receive the capsule at home, which you can swallow to allow doctors to see how your colon is doing without needing to go to a hospital. This could be a great option for those looking for a less invasive and more convenient way to get important health information.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who have been selected by overseeing clinician meeting NHS England criteria to undergo colon capsule endoscopy as part of their standard of care
• • Age between 18-55
• Exclusion Criteria:
• • Patients unable or unwilling to provide consent to take part in the study
• • Patient is pregnant
• • Standard CCE exclusion criteria